The Patient Simulators Market is expected to grow from US$ 1,599.41 million in 2021 to US$ 4,284.03 million by 2028; it is estimated to register a CAGR of 15.2% from 2022 to 2028.
The market growth is attributed to the growing use of patient simulators for training purposes and the increasing demand for minimally invasive treatment methods. However, the high cost of patient simulators hampers the market growth.
A patient simulator is a manikin that mimics human anatomy or function (physiology), which can be used to train students and healthcare professionals. Clinical simulation allows practitioners of all levels and healthcare disciplines to practice and improve their clinical skills without any potential harm to patients. Patient simulators are most frequently used in academic institutions, academic medical centers, government research organizations, hospitals & clinics, and military training centers.
For More Insights: https://www.premiummarketinsig....hts.com/reports-tip/
1 (877) 773-1002